2. Signaling Pathways
  3. Membrane Transporter/Ion Channel
    Neuronal Signaling
  4. iGluR
  5. Kainate Receptor Isoform
  6. Kainate Receptor Antagonist

Kainate Receptor Antagonist

Kainate Receptor Antagonists (3):

Cat. No. Product Name Effect Purity
  • HY-15067
    DNQX
    		Antagonist 98.45%
    DNQX (FG 9041), a quinoxaline derivative, is a selective, potent competitive non-NMDA glutamate receptor antagonist (IC50s = 0.5, 2 and 40 μM for AMPA, kainate and NMDA receptors, respectively).
  • HY-103234A
    GYKI 52466 dihydrochloride
    		Antagonist 99.38%
    GYKI 52466 dihydrochloride is an orally active, highly selective and noncompetitive AMPA/kainate receptor antagonist with the IC50 values of 7.5 and 11μM, respectively.
  • HY-103234
    GYKI 52466
    		Antagonist
    GYKI 52466 is an orally active, highly selective and noncompetitive AMPA/kainate receptor antagonist with the IC50 values of 7.5 and 11μM, respectively.